A retrospective evaluation of soft tissue tumors that have undergone core needle biopsy with US guidance (US-CNB)
The present study is designed to be the first step in the creation of an interdisciplinary platform collecting data on patients and procedures to provide a predictive tool to help physicians in the management of patients affected by a soft tissue lesion. The primary aim of our work is to evaluate the diagnostic yield of US-CNB. The secondary aim is to exploit all the imaging data conventionally available at a Sarcoma Center before a biopsy on a soft tissue mass, to build a multiparametric model and score of prediction of malignancy, and eventually of biological behavior - grading.
Study Type
OBSERVATIONAL
Enrollment
350
The Rizzoli Orthopaedic Institute
Bologna, Bo, Italy
Diagnostic yield
Diagnostic yield will be defined as the number of diagnostic core needle biopsies divided by the total number of core needle biopsies. A diagnostic yield \> 94% will be considered sufficient to produce a sample to reach the histological diagnosis.
Time frame: One year
Prediction of malignancy
To determine which imaging features and biomarkers correlates with malignancy and biological behavior of soft tissue masses.
Time frame: One year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.